G
Genecis Bioindustries
Uses biotechnology to convert waste into high value materials, including PHA bioplastics
About Genecis Bioindustries
Genecis Bioindustries is a climate biotechnology company focused on transforming organic waste into sustainable and biodegradable materials. Operating in the environmental and materials science sectors, Genecis serves a diverse range of clients including businesses in packaging, automotive, and textiles industries. The company’s core product is Polyhydroxyalkanoates (PHA), a biodegradable plastic alternative that offers the same functionality as traditional oil-based plastics without the associated pollution. Genecis generates revenue through partnerships with businesses interested in custom polymer formulation, rapid product development, and co-branding opportunities. The business model is centered around creating a circular economy by converting organic waste into PHA, which can then be composted and upcycled into new products at the end of their lifecycle. This approach not only addresses the growing issue of plastic waste but also provides a sustainable alternative that aligns with increasing regulatory pressures to ban single-use plastics.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Toronto, Canada
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 70.5/100
- Sub-industry
- Waste Solution
- Sector
- Energy, Biotechnology, Plastic, Synthetic Biology, Waste Reduction, Spinout, Food Waste, Sustainable Packaging, Sustainable Development Goals, Industrial Technology, Advanced Materials
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2023 | $17M | $68M | Amazon · Khosla Ventures | ↗ |
| GRANTOther financing | Jun 2023 | $150K | — | Ontario Genomics | ↗ |
Growth signals
Latest recorded traffic for Genecis Bioindustries is 150 monthly website visits, up 0% over the last three months. Genecis Bioindustries's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
- SFSocial Enterprise Fund
BASF
Sustainable Development Technology Canada
Asymmetry Ventures
Y Combinator
INP Capital
Ontario Genomics
Series A8 investors entered at this stage
Business Development Bank of Canada
Khosla Ventures
AME Cloud Ventures
Gullspång Re:food
BDC Capital
IT-Farm
The Kraft Heinz CompanyAmazon
Series B and later2 investors entered at this stage
Standard Treasury
Silicon Valley Bank
Other known investors13 additional known investors
University of Toronto
Allied Venture Partners
Capital Angel Network- CPCeltic House Asia Partners
Creative Destruction Lab
Emerald Technology Ventures
Golden Triangle Angelnet
Green Century Investment
Helium-3 Ventures- NFNatural Bridge Fund
Phoebe Wang
The Climate Pledge
Virta Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genecis Bioindustries on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genecis Bioindustries’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.